The Effects of Hypobaria vs Hypoxia on Cerebral Functions.

Sponsor
Fliegerärztliches Institut (Other)
Overall Status
Completed
CT.gov ID
NCT03303118
Collaborator
(none)
17
1
1
3.6
4.7

Study Details

Study Description

Brief Summary

The investigators will investigate the effect of hypobaria and hypoxia on physiological responses such as: oxygen saturation, heart rate, cerebral blood flow, cerebral oxygenation, brain's activity and concentration performance.

Condition or Disease Intervention/Treatment Phase
  • Other: Hypoxia
N/A

Detailed Description

The main goal of this project is to investigate how hypoxia affects cognitive functions. The KLT-R test asses the concentration level of a person. Subjects will do this test at different simulated altitude level in the hypobaric chamber at the FAI in Dübendorf. Investigators' first hypothesis is that concentration level will be altered by hypoxia. The higher altitude the subjects are, the more the concentration would be altered. KLT-R performance would be impaired by hypoxia compare to sea level performance.

The primary endpoint of this project is to investigate how KLT-R performance is affected by the different hypoxic conditions. KLT-R test will be passed nine times in total during the test visit. There will be a pre-test; a test at each of the conditions (3000m HH, 5500m HH, 5500m NH and 5500m HN); between each condition at sea level (to have a new baseline before each condition) and a post-test at the end of the protocol. To avoid influence of fatigue, all conditions will be randomized.

The second endpoint of this study is how the brain electrical activity is modulated by hypoxia. Micro-states also will be measure during hypobaric hypoxia conditions (3000m HH and 5500m HH).

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single-Blind study.Single-Blind study.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Effects of Hypobaria vs Hypoxia on Cerebral Vasoreactivity, Brain's Electrical Activity and Concentration Performance on Pilots.
Actual Study Start Date :
Nov 16, 2017
Actual Primary Completion Date :
Mar 5, 2018
Actual Study Completion Date :
Mar 5, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: Left

No product administration will be done in this study.

Other: Hypoxia
No drug or product will be used in this study. No medication will be give to the participants. No arm will be used for product administration.

Outcome Measures

Primary Outcome Measures

  1. Concentration performance [4 minutes per test]

    Performance of concentration at different altitude levels.

Secondary Outcome Measures

  1. EEG micro-states [5 minutes per record]

    5 minutes recording in each conditions, eyes closed, at rest.

Other Outcome Measures

  1. Cerebral vaso-reactivity [8 Minutes per test]

    Cerebral vasoreactivity after 1 minute hyperventilation and 3 minutes breathing of 5% CO2 mixture.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • No history of flight sickness

  • No relevant medical diseases

  • Age 18 - 40 years

  • Written consent acceptance

Exclusion Criteria:
  • Known pathologies

  • Relevant medical disorders

  • Drug addiction

  • Anemia or poor health

  • People who have already had problems with elevation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mathias Aebi Dübendorf Zürich Switzerland 8600

Sponsors and Collaborators

  • Fliegerärztliches Institut

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mathias Aebi, PhD, Dr. med Denis Bron, Fliegerärztliches Institut
ClinicalTrials.gov Identifier:
NCT03303118
Other Study ID Numbers:
  • 2017-00752
First Posted:
Oct 5, 2017
Last Update Posted:
Aug 18, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mathias Aebi, PhD, Dr. med Denis Bron, Fliegerärztliches Institut
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2021